KNE.V - Kane Biotech Inc.

TSXV - TSXV Real Time Price. Currency in CAD
Currency in CAD

Valuation Measures4

Market Cap (intraday) 11.86M
Enterprise Value 18.80M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)4.21
Price/Book (mrq)2.17
Enterprise Value/Revenue 6.76
Enterprise Value/EBITDA -6.76

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 311.11%
S&P500 52-Week Change 33.90%
52 Week High 30.1500
52 Week Low 30.0800
50-Day Moving Average 30.1142
200-Day Moving Average 30.1040

Share Statistics

Avg Vol (3 month) 352.63k
Avg Vol (10 day) 3145.9k
Shares Outstanding 5124.85M
Implied Shares Outstanding 6N/A
Float 8N/A
% Held by Insiders 126.83%
% Held by Institutions 10.00%
Shares Short (May 14, 2023) 45k
Short Ratio (May 14, 2023) 40.09
Short % of Float (May 14, 2023) 4N/A
Short % of Shares Outstanding (May 14, 2023) 40.00%
Shares Short (prior month Apr 13, 2023) 48.88k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Mar 12, 2017
Ex-Dividend Date 4N/A
Last Split Factor 21:5
Last Split Date 3Mar 12, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Mar 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)0.02
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)1.41M
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)-0.0300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)N/A
Book Value Per Share (mrq)-0.05

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A